Replies to post #4598 on Halozyme Therapeutics Inc (HALO)

[rod5247]

"The fact that PEGPH20 was discontinued for about 3 months complicates things"

Peg was discontinued in stage I period. Recruitment was stopped. All patients moved to the AG arm.

Sure does complicate things. Makes the PAG data weaker and the AG data stronger.

Should not be any surprise since the basic data and circumstance has been known for over a year.

No idea what the market was expecting but the huge short position will grasp at anything to turn a positive into a negative.